YOLFTbeta
SEI Medical Public Company Limited

SEI Medical Public Company Limited

SEI · BK · Healthcare / Medical Distribution

1.67THB-0.05 (-2.91%)

Price History

Full chart

Market Stats

Previous Close1.72
Open1.72
Day Range1.65 – 1.72
52-Week Range1.49 – 2.57
Volume175.90K
Market Cap340.00M
P/E (TTM)11.11
Forward P/E0.00
EPS0.18
Dividend Yield5.56%
Beta0.29
50-Day Avg1.79
200-Day Avg1.95

About

SEI Medical Public Company Limited engages in the distribution of scientific instruments and medical equipment in Thailand. The company offers endoscopy, surgical, aesthetic, neonatal care, and laboratory equipment. It is also involved in the service and medical equipment lease contract businesses. The company was founded in 1986 and is based in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Karn Punyacharoensin
  • Employees0
  • Headquarters546 Ratchada One Building, Bangkok, Thailand, 10900, Thailand
  • Websitehttps://www.sei.co.th

Leadership

  • Mr. Karn PunyacharoensinCEO & Director · b. 1983
  • Mr. Phonlaphat MahapooranonChief Financial Officer
  • Ms. Suchada TiviratAccounting Manager
  • Ms. Viparrat HeanchasriChief Sales and Marketing Officer & Director
  • Ms. Nichakarn ChumnanAssistant Director of Sustainability Development

Financials

Income Statement

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Total Revenue320.55M393.57M443.98M449.68M
Growth (%)-+22.78%+12.81%+1.28%
Cost of Revenue219.11M277.26M289.66M293.41M
Gross Profit101.44M116.31M154.32M156.26M
Gross Margin31.65%29.55%34.76%34.75%
Operating Expense78.17M86.38M89.11M98.75M
Operating Income23.27M29.93M65.21M57.51M
Operating Margin7.26%7.61%14.69%12.79%
EBITDA42.19M45.62M81.99M75.58M
EBITDA Margin13.16%11.59%18.47%16.81%
Net Income17.86M21.87M52.23M46.50M
Net Income Margin5.57%5.56%11.76%10.34%
Interest Expense2.78M3.29M3.34M2.16M
Interest Expense % of Total Revenue0.87%0.84%0.75%0.48%

Balance Sheet

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Total Assets279.45M302.43M461.10M514.99M
Total Liabilities251.09M223.20M178.21M202.98M
Total Equity28.36M79.23M282.89M312.01M
Cash34.56M8.51M174.23M176.64M
Net Debt53.94M102.50M--

Cash Flow

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow45.60M-15.52M53.24M71.03M
Financing Cash Flow-34.33M-1.77M122.67M-16.63M
Capital Expenditure12.53M14.83M13.62M35.45M
Free Cash Flow33.07M-30.36M39.62M35.57M
Dividends Paid60.00M75.00M020.37M
FCF to OCF72.53%195.57%74.42%50.08%
Dividend Paid to FCF181.42%-247.07%0.00%57.26%

Earnings

Report DateNov 13, 2024Feb 27, 2025Mar 31, 2025Aug 7, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.080.070.120.05----
EPS Actual0.150.080.130.050.060.030.050.04
Surprise87.50%14.29%8.33%0.00%----
TimingAfter-hoursAfter-hours-Pre-market----

Key Statistics & Ratios

Market Cap340.00M
Enterprise Value327.76M
Trailing P/E11.11
Forward P/E0.00
Price / Sales0.83
Price / Book1.04
EPS0.18
Book Value1.81
Revenue (TTM)411.51M
Gross Profit (TTM)152.30M
EBITDA54.70M
Profit Margin7.50%
Operating Margin7.93%
Return on Equity10.31%
Return on Assets4.93%
Shares Outstanding170.00M
Shares Float50.00M
Beta0.29
Dividend Yield5.56%
Dividend Rate0.11
Payout Ratio60.54%

Dividends

20261×
0.11Mar 12, 2026
20251×
0.12Mar 14, 2025